Abstract:Abstract Background Head and neck squamous cell carcinoma (HNSCC) is characterized by the highly infiltrative capacity and invariably aggressive feature, the oncogenic functions of TERT in cell transformation and tumor progression have well been elucidated; however, very little is known about the effect of TERT on the microenvironment during the tumorigenesis of HNSCC. Methods An bioinformatics analysis of TERT was firstly performed from TCGA dataset, and the correlation of TERT activity with tumor microenvironment (TME) was assessed on the basis of the analysis of HNSCC patient specimen in vivo and in vitro co-culture experiments. We next conducted an cDNA microarray analysis and identified the TERT-driven key molecule MET in the functionally regulation of tumor-fibroblasts crosstalk. Furthermore, the phenotypic and functional alteration of primary fibroblasts were detected by a series of molecular biology experiments following treatment with TERT overexpressed/silenced HNSCC cell-derived exosomes or MET transfection, respectively, and the underlying intracellular signaling pathway was tested. Finally, the effect of programming fibroblasts on the aggressive behavior of HNSCC cells were evaluated in vivo and in vitro assays. Results Here, we found that TERT was significantly elevated in HNSCC tissues in comparison with normal mucosa tissues, and its level was increased along with malignant progression of the tumor. Furthermore, the activated TERT enhanced cancer-fibroblasts interaction and promoted cancer-associated fibroblasts (CAFs) formation in TME. Mechanistically, TERT-driven normal fibroblast reprogramming into CAFs is exosomal MET dependent, activated TERT could physically interact with MET protein and increase exosomal MET protein released from HNSCC cells, which promotes the intercellular trafficking of MET into fibroblasts and consequently activated AKT and ERK signaling pathways, resulting in primary fibroblast reprogramming through increased cell proliferation, migration and elevation of the pro-inflammatory gene signature. More importantly, the programmed fibroblasts in turn promote the migration and invasion of HNSCC cells. Conclusions Our results unveil a novel role of TERT-driven modulation of the TME, which may offer new opportunities for potential therapeutic strategies targeting HNSCC development.

Htert Promotes Tumor Angiogenesis by Activating Vegf Via Interactions with the Sp1 Transcription Factor

Argininosuccinate Lyase Drives Activation of Mutant TERT Promoter in Glioblastomas

hTERT promotes cell adhesion and migration independent of telomerase activity

TERT Drives Fibroblasts Reprogramming to Promote the Invasion of Head and Neck Squamous Cell Carcinoma Via Transferring of Exosomal MET Protein

Telomerase Reverse Transcriptase Promotes Epithelial–mesenchymal Transition and Stem Cell-Like Traits in Cancer Cells

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications

Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells

Telomerase Reverse Transcriptase Promotes the Proliferation of Human Laryngeal Carcinoma Cells Through Activation of the Activator Protein 1

Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.

Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro.

Immunotherapy of Tumors with Human Telomerase Reverse Transcriptase Immortalized Human Umbilical Vein Endothelial Cells.

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

The Regulatory Function of Tandem Repeat VNTR2‐1 in Htert Gene Involves Basic Helix–loop–helix Family Transcription Factors

hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression

Tumor-specific Activation of Human Telomerase Reverses Transcriptase Promoter Activity by Activating Enhancer-binding Protein-2β in Human Lung Cancer Cells

SPT6 Recruits SND1 to Co‐activate Human Telomerase Reverse Transcriptase to Promote Colon Cancer Progression

TERC Promotes Non-Small Cell Lung Cancer Progression by Facilitating the Nuclear Localization of TERT

TERT activates endogenous retroviruses to promote an immunosuppressive tumour microenvironment

hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.

Synergistic Activation of Mutant TERT Promoter by Sp1 and GABPA in BRAFV600E-driven Human Cancers

Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription.